Revenue seems to be slipping in the acute sector but they are doing well in non-acute. Seems the 500k research grant is no more so that's also impacted 'revenue'.
Higher salaries and expenses probably due to the SA dispute.
Now that they are cashed up hopefully they can further develop their products.
Ann: Dividend/Distribution - GLH, page-4
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add GLH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.965M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 40000 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.0¢ | 2389 | 1 |
View Market Depth
| Last trade - 16.12pm 30/08/2024 (20 minute delay) ? |
| GLH (ASX) Chart |
Day chart unavailable